Atlas Trials

Study on the Use of Sarilumab in Patients With COVID-19 Infection

Clinical trial NCT04386239 · WITHDRAWN

Trial details

NCT number
NCT04386239
Sponsor
ASST Fatebenefratelli Sacco
Status
WITHDRAWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
COVID19
Start date
2021-01-01
Primary completion
2023-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.